Frequently bought together

Brand : FLEXO FYTOL

FLEXOFYTOL CAP 60/CAP

Sku : I-026263
Key features
FLEXOFYTOL CAP is a soft gelatin capsule supplement containing turmeric rhizome extract (Curcuma longa L.) standardized to a 42 mg curcuminoid complex per capsule. It supports joint health and helps reduce inflammation, intended for individuals seeking targeted joint comfort and mobility support. Its proprietary lipid-based formulation in a soft capsule significantly enhances curcumin absorption compared with standard turmeric powder, improving delivery of the active curcuminoid complex. Serving size is one soft capsule, supplied in a 60-capsule pack.
- Brand: FLEXO FYTOL
- Supplement Type: Herbal
- Active Compounds: Turmeric rhizome extract (Curcuma longa L.) 42mg - standardized curcuminoid complex in lipid-based soft capsule for enhanced bioavailability
- Supplement Form: capsule, soft
- Serving Size: 1 soft capsule
- Servings Per Container: 60
- Pack Size: 60 Capsules
- Primary Benefit: Supports joint health and reduces inflammation through highly bioavailable curcumin derived from turmeric rhizome extract
- Bioavailability Form: Lipid-formulated curcumin in soft gelatin capsule (Flexofytol proprietary formulation) - significantly enhances curcumin absorption compared to standard turmeric powder due to lipid matrix delivery system
- Prescription Status: OTC
- Certification: SFDA registered (Registration No. 903200029); manufactured by Tilman S.A. (Belgium) under GMP standards
- Manufacturer: TILMAN S . A
- Country of Origin: Belgium
- SFDA Registration No.: 903200029
- Shelf Life: 36 months
- Calcium Included: No
- Vitamin K Included: No

Frequently bought together

Description

Specification

Benefits & Uses

Primary Benefit

Supports joint health and reduces inflammation through highly bioavailable curcumin derived from turmeric rhizome extract

Health Claims

Supports joint comfort and mobility; contributes to reduction of joint inflammation; antioxidant properties help protect cells from oxidative stress; supports healthy inflammatory response

Common Deficiency Symptoms

Not applicable - curcumin is not an essential nutrient; conditions associated with low curcumin intake include increased joint inflammation and oxidative stress

Target Population

Adults with joint discomfort, osteoarthritis, or inflammatory conditions; individuals seeking natural anti-inflammatory support; adults over 40 with age-related joint concerns

Scientific Evidence Level

Moderate

Onset Timeline

Joint comfort improvements typically reported within 4-8 weeks of consistent daily use; anti-inflammatory biomarker changes may be observed within 2-4 weeks

Usage & Dosage

Suggested Use

Take 2 soft capsules twice daily with meals

Serving Size

1 soft capsule

Servings Per Container

Best Time to Take

With meals

Recommended Daily Intake

No established RDI for curcumin; clinical studies typically use 180-500mg curcuminoids/day for joint and anti-inflammatory benefits

Absorption Enhancers

The formulation uses an emulsifier (polysorbate 80) to increase bioavailability. Taking with a fat-containing meal can also enhance absorption of curcuminoids.

Side Effects

Possible Side Effects

Generally well-tolerated at recommended doses; high doses may cause nausea, diarrhea, stomach upset, or headache; rare cases of allergic skin reactions reported

Toxicity Risk

Low

Interactions

Synergistic Nutrients

No synergistic nutrients included; Flexofytol uses polysorbate 80 emulsifier for bioavailability

Special Populations

Target Population

Adults with joint discomfort, osteoarthritis, or inflammatory conditions; individuals seeking natural anti-inflammatory support; adults over 40 with age-related joint concerns

Storage & Patient Advice

SFDA Storage Conditions

store below 25°c

Science & Evidence

Bioavailability Form

Lipid-formulated curcumin in soft gelatin capsule (Flexofytol proprietary formulation) - significantly enhances curcumin absorption compared to standard turmeric powder due to lipid matrix delivery system

Water or Fat Soluble

Fat-soluble

Scientific Evidence Level

Moderate

Onset Timeline

Joint comfort improvements typically reported within 4-8 weeks of consistent daily use; anti-inflammatory biomarker changes may be observed within 2-4 weeks